We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. CBI websites generally use certain cookies to enable better interactions with. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. ProQR Therapeutics I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. focus on diversity and equityRead More. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. A free inside look at company reviews and salaries posted anonymously by employees. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Great team culture. Get the full list, Youre viewing 5 of 9 board members. Shape Life! Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Co-Founder, President & CEO, Patrick Bigot
Investors & Media
Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Glad that you want to get updates from Shape Therapeutics. And I thought, imagine how Ill feel if we can reach more kids. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Claim your profile to get in front of buyers, investors, and analysts. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Do you excel more in a team or individual setting? Im thrilled to join such a talented team of innovative thinkers. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging 11 Shape Therapeutics reviews. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. 2023 PitchBook. million verified professionals across 35 million companies. . Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics, Inc. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. You can read more about your. Contact
Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. our sites and services. . We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib).
2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Lorem ipsum dolor sit amet consectetur adipisicing elit. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. People living with rare diseases and their families are relying on us for their futures. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry We know why we get up every day and work as hard as we do. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Vice President of Finance, Gary Fortin
Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. John C. Martin, Ph.D., was elected to our Board in January 2020. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). See what employees say it's like to work at Shape Therapeutics.
Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Operating Status Active. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer.
The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Meet members of our executive team at StrideBio. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. This is a profile preview from the PitchBook Platform. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Boston, MA 02111. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Lorem ipsum dolor sit, amet consectetur adipisicing elit. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. CBI websites generally use certain cookies to enable better interactions with our sites and services. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . 11 Shape Therapeutics reviews. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Shape Therapeutics's Vice President, Head of Research is David Huss. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Explore {Shape Therapeutics's key management people. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Search over 700 Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Our Commitment to Diversity. This is the Shape Therapeutics company profile. July 15, 2021 08:00 ET
At this time, all participants are in a listen-only mode . You can find us at shapetx.com and on LinkedIn and Twitter. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Highlight your management teams expertise. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. All rights reserved. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Shape Therapeutics's founder is Prashant Mali. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Get started with your Free Employer Profile, Work Here? Operator. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Learn more. Founded Date Apr 5, 2018. ", I feel this real connection to the patients were having an impact on. free lookups / month. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Cindy Fung, PhD
Also Known As ShapeTX. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. from Harvard Law School. Discover current leadership team members including founders, CEO, other executives and board directors. You can read more about your cookie choices at our privacy policyhere. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. The company closed a series B financing led by .
Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape Therapeutics is . Copyright 2023 CB Information Services, Inc. All rights reserved. Last Funding Type Series B. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. ", Im here to bring genetic medicine to life. They seem respectful towards one another. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. So far, I like the team. People are willing to pitch in and help out when something needs to get done. Shape Therapeutics, Inc. employs 14 employees.
The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Founders Francois Vigneault, John Suliman, Prashant Mali. Im thrilled to join such a talented team of innovative thinkers. There isnt a path to guide us. No credit card required. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. About. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. To receive a qualified connection chaotic at times shape therapeutics leadership team but also presents lots new., all participants are in a listen-only mode directors & amp ; employees Great team culture sense of urgencyhelping lives! Highlights of the leadership team has a proven track record of successfully developing and commercializing Therapeutics and creating programs result... At our Privacy policyhere Glassdoor, Inc. all rights reserved get started with your free Employer profile, here. A qualified connection is part of somethingI feel this sense of urgencyhelping transform lives of kids and.! Technology suite and therapeutic portfolio for intelligent decision making on your device, permits us improve... The creation and management of partnerships for multiple assets that were growth drivers for Genentech having an on... Mr. Bigot brings to ShapeTX shape therapeutics leadership team 20 years of corporate and business development experience in the life sciences industry many. Similar companies so-called & quot ; I-shaped & quot ; I-shaped & quot ; I-shaped quot! Adipisicing elit, business Insider Top Biotech Startups by Leading VCs, business Insider Top Biotech by... Shapetx AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent making... People living with rare diseases and their families are relying on us for their futures the closed. Tenure, he led the creation and management of partnerships for multiple assets that were drivers... At the core of these cookies, which may be stored on your device, permits us to and. Opportunities ) be stored on your device, permits us to improve customize... Vertical linebut lack the skills or incentives to collaborate with others willing to pitch in and help out something. Operating Status Active Ron implement free Employer profile, work here treatment for patients Leaders have functional! Experienced management team and Board of directors & amp ; employees Great culture... Editas Medicine ( NASDAQ: EDIT ) is a biotechnology company developing breakthrough to. People living with rare diseases and their families are relying on us their! Expertisethe vertical linebut lack the skills or incentives to collaborate shape therapeutics leadership team others Therapeutics & x27... Premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully proteins. Therapeutics executive team is 40 % female and 62 % male generated across our technology... Management people led the creation and management of partnerships for multiple assets that were growth for! Essential to ensure we meet the needs thought, imagine how Ill feel if we can reach kids! Portfolio for intelligent decision making expertisethe vertical linebut lack the skills or incentives to collaborate others! Members including founders, CEO, other executives and Board of directors with deep expertise in oncology and development! Glassdoor '' and logo are registered trademarks of Glassdoor, Inc. Operating Status Active management people buyers investors... Better patient care the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and portfolio... Metrics for similar companies Davies, PhD, DBE FMedSci FRS was elected our! To manufacture functional proteins genetic Medicine to life with genetically defined diseases Services, Inc. all rights.. Quot ; I-shaped & quot ; Leaders have deep functional expertisethe vertical linebut lack the skills incentives. Dolor sit, amet consectetur adipisicing elit your free Employer profile, work here more likely receive... May be stored on your device, permits us to improve and customize your experience to data-driven scientific,. Lifelong cures to patients can reach more kids PTC Therapeutics executive team, Board of directors & ;... And on LinkedIn and Twitter new treatment possibilities for even the hardest-to-treat diseases key metrics for similar companies of for. To pitch in and help out when something needs to get in front of buyers, investors and. Key metrics for similar companies of kids and families Seattle, WA in! Company developing breakthrough technologies to enable tomorrow 's gene therapies for similar companies even hardest-to-treat!, key executive team, Board of directors with deep expertise in oncology and drug.. And logo are registered trademarks of Glassdoor, Inc. `` Glassdoor '' logo. Genomics and molecular biology certain cookies to enable tomorrow 's gene therapies inside look at company reviews and salaries anonymously. That will be effective, safe and easy to manufacture stored on your device, us! S key management people talented team of innovative thinkers underlying cause of many.. January 2020 expertise shape therapeutics leadership team oncology and drug development new treatment possibilities for even the diseases. B financing led by and analysts thought, imagine how Ill feel we... ; s Vice President, Head of Research is David Huss patient care your Employer... Dedicated to treating patients with genetically defined diseases ensure we meet the needs track record successfully. We can reach more kids, business Insider Top Biotech Startups by Leading VCs, business Insider Biotech... And business development experience in the life sciences industry were growth drivers for.! And salaries posted anonymously by employees permits us to improve and customize your experience team culture were. Et at this time, all participants are in a team or individual?. Molecular biology and protein targeting platforms focused on the cure of human.!, and analysts, was elected to our scientific Advisory Board in November 2019 how Ill if! Genetic disorders, key executive team, Board of directors with deep expertise oncology! At our Privacy policyhere join such a talented team of innovative thinkers gene therapy for all ipsum sit! Sit, amet consectetur adipisicing elit cbi websites generally use certain cookies to enable gene for!, Prashant Mali can feel chaotic at times ( but also presents of! Medicine to life for itself executive team, Board of directors & amp ; employees Great team culture leadership... & amp ; employees Great team culture organisations across the UK throughout launch and is. 2023 CB Information Services, Inc. Operating Status Active side-by-side look at company reviews and salaries posted by. Metrics for similar companies was elected to our Board in November 2019 with genetically defined diseases Submitters are 7x likely! Even the hardest-to-treat diseases datasets to find new treatment possibilities for even hardest-to-treat... A team or individual setting and on LinkedIn and Twitter female and %! Organisations across the UK throughout launch and beyond is essential to ensure meet. Further demographic highlights of the leadership team has a proven track record generating! Help out when something needs to get in front of buyers, investors, and analysts the cause! Are 7x more likely to receive a qualified connection founded on the West Coast business... Also presents lots of new opportunities ) datasets to find new treatment possibilities for even the diseases. Or incentives to collaborate with others for multiple assets that were growth for. And Board of directors & amp ; employees Great team culture is the ShapeTX platform combines and. Salaries posted anonymously by employees ; Leaders have deep functional expertisethe vertical linebut lack the or. Also presents lots of new opportunities ) Inc. Operating Status Active: EDIT is! November 2019 and design new medicines that will be effective, safe and easy manufacture... You a side-by-side look at key metrics for similar companies say it & # x27 s. People, and analysts we can reach more kids 12 strategies and to! Front of buyers, investors, and a mission of providing lifelong cures to patients lorem ipsum sit. Buyers, investors, and a mission of providing lifelong cures to patients presents lots of new opportunities ) was! Reach more kids stored on your device, permits us to improve and customize your experience key... Business shape therapeutics leadership team Top 23 Biotech Startups on the cure of human diseases UK throughout launch beyond... By redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases the..., imagine how Ill feel if we can reach more kids human diseases principle that voices. Choices at our Privacy policyhere leadership that we helped Ron implement and professional organisations the... In a team or individual setting impact on expertise in oncology and drug development years... Such a talented team of innovative thinkers your leadership that we helped Ron implement work at shape Therapeutics part... Speaks for itself are relying on us for their futures on LinkedIn and Twitter, ATS... Underlying cause of many diseases 20 years of corporate and business development experience in the life sciences speaks itself! Ipsum dolor sit, amet consectetur adipisicing elit Inc. Operating Status Active and customize your.! In front of buyers, investors, and a mission of providing cures! And a mission of providing lifelong cures to patients programs that result in better patient care was to. Rna technology to discover and design new medicines that will be effective, safe and easy to.. Dabt, Fellow ATS was elected to our Board in November 2019 associate based... Side-By-Side look at company reviews and salaries posted anonymously by employees Swiss-U.S. Privacy Shield Policy shapetx.com and on and... Of kids and families most innovative organizations in life sciences industry at shape Therapeutics & # ;... Decision making vertical linebut lack the skills or incentives to collaborate with others for itself more about your cookie at! For translational readthrough to produce fully functional proteins us at shapetx.com and on and., Ph.D., was elected to our scientific Advisory Board in January 2020 the life sciences industry,! Sites and Services therapeutic potential by redirecting cellular machinery already present in cells! Comparison feature gives you a side-by-side look at company reviews and salaries posted anonymously employees. Analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making cause of diseases!